Nuveen Asset Management, LLC Teva Pharmaceutical Industries LTD Transaction History

Nuveen Asset Management, LLC

$334 Billion
Q2 2024

A detailed history of Nuveen Asset Management, LLC transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 2,596,833 shares of TEVA stock, worth $45.4 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

2,596,833

Previous 2,636,066 1.49%

Holding current value

$45.4 Million

Previous $37.2 Million 13.45%

% of portfolio

0.01%

Previous 0.01%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	SELL	$12.78 - $17.4 $501,397 - $682,654	-39,233 Reduced 1.49%	2,596,833 $42.2 Million
Q1 2024 May 13, 2024	BUY	$10.67 - $14.43 $10.4 Million - $14.1 Million	975,556 Added 58.75%	2,636,066 $37.2 Million
Q4 2023 Feb 14, 2024	BUY	$8.12 - $10.63 $439,291 - $575,083	54,100 Added 3.37%	1,660,510 $17.3 Million
Q3 2023 Nov 14, 2023	BUY	$7.48 - $10.7 $792,880 - $1.13 Million	106,000 Added 7.06%	1,606,410 $16.4 Million
Q2 2023 Aug 14, 2023	BUY	$7.2 - $9.47 $170,640 - $224,439	23,700 Added 1.6%	1,500,410 $11.3 Million
Q1 2023 May 15, 2023	BUY	$8.36 - $11.37 $1.02 Million - $1.38 Million	121,600 Added 8.97%	1,476,710 $13.1 Million
Q4 2022 Feb 14, 2023	SELL	$7.95 - $9.48 $1.8 Million - $2.14 Million	-226,154 Reduced 14.3%	1,355,110 $12.4 Million
Q3 2022 Nov 14, 2022	BUY	$6.86 - $11.95 $916,351 - $1.6 Million	133,579 Added 9.23%	1,581,264 $12.8 Million
Q2 2022 Aug 15, 2022	SELL	$7.38 - $10.4 $263,783 - $371,727	-35,743 Reduced 2.41%	1,447,685 $10.9 Million
Q1 2022 May 16, 2022	SELL	$7.33 - $9.39 $472,601 - $605,420	-64,475 Reduced 4.17%	1,483,428 $13.9 Million
Q4 2021 Feb 14, 2022	BUY	$7.9 - $10.19 $1.65 Million - $2.13 Million	209,321 Added 15.64%	1,547,903 $12.4 Million
Q3 2021 Nov 12, 2021	BUY	$8.38 - $10.18 $1.59 Million - $1.94 Million	190,102 Added 16.55%	1,338,582 $13 Million
Q2 2021 Aug 16, 2021	SELL	$9.9 - $11.56 $2.58 Million - $3.01 Million	-260,506 Reduced 18.49%	1,148,480 $11.4 Million
Q1 2021 May 17, 2021	SELL	$10.34 - $12.81 $1.18 Million - $1.46 Million	-114,337 Reduced 7.51%	1,408,986 $16.3 Million
Q4 2020 Feb 16, 2021	SELL	$8.61 - $11.04 $6.68 Million - $8.57 Million	-776,015 Reduced 33.75%	1,523,323 $14.7 Million
Q3 2020 Nov 16, 2020	BUY	$8.57 - $12.69 $1.19 Million - $1.77 Million	139,401 Added 6.45%	2,299,338 $20.7 Million
Q2 2020 Aug 14, 2020	BUY	$8.12 - $13.12 $6.46 Million - $10.4 Million	795,681 Added 58.32%	2,159,937 $26.6 Million
Q1 2020 May 14, 2020	SELL	$6.69 - $13.45 $6.15 Million - $12.4 Million	-919,450 Reduced 40.26%	1,364,256 $12.3 Million
Q4 2019 Feb 14, 2020	SELL	$6.53 - $10.72 $3.13 Million - $5.14 Million	-479,827 Reduced 17.36%	2,283,706 $22.4 Million
Q3 2019 Nov 14, 2019	SELL	$6.16 - $9.6 $4.75 Million - $7.4 Million	-771,084 Reduced 21.82%	2,763,533 $19 Million
Q2 2019 Aug 15, 2019	BUY	$8.12 - $15.72 $28.7 Million - $55.6 Million	3,534,617 New	3,534,617 $32.6 Million

Others Institutions Holding TEVA

# of Institutions

617

Shares Held

563M

Call Options Held

25.2M

Put Options Held

5.08M

View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $19.4B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

More about TEVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account

Nuveen Asset Management, LLC Teva Pharmaceutical Industries LTD Transaction History